Meet the media team
Find a media contact in your region
News Our latest updates and announcements
- Africa
- Africa Group
- Johannesburg
- Americas
- Latin America Group
- New York
- Asia
- Bangkok
- Hong Kong
- India Group
- Jakarta
- Korea Group
- Mainland China
- Malaysia Group
- Singapore
- Tokyo
- Vietnam Group
- Australia
- Brisbane
- Melbourne
- Perth
- Sydney
- Europe
- Belfast
- Brussels
- Central Asia Group
- Germany
- Kazakhstan Group
- London
- London - Canary Wharf
- Luxembourg
- Madrid
- Milan
- Nordic Group
- Paris
- Switzerland Group
- Ukraine Group
- Middle East
- Dubai
- Israel Group
- Riyadh
- telecommunications
- Agribusiness
- Automotive
- Connected and Autonomous Vehicles
- Electrification
- Mobility as a service
- Consumer
- Energy
- Energy Disputes
- Energy Mergers and Acquisitions
- Nuclear
- Oil and Gas
- Power
- Renewables
- Financial Buyers
- Financial Institutions
- Asset and Wealth Management
- Banks
- Fintech
- Insurance
- Government and Public Sector
- Infrastructure
- Airports
- Aviation
- Defence
- Digital infrastructure
- PPP
- Ports
- Rail
- Roads
- Social Infrastructure
- Water and Waste
- Leisure and Sport
- Sports Disputes
- Manufacturing and Industrials
- Mining
- Pharmaceuticals and Healthcare
- Diagnostics and medical Devices
- Healthcare
- Pharmaceuticals
- Pharmaceuticals and Healthcare regulatory
- Private Capital
- Leveraged Finance
- Private Equity
- Real Assets: Energy and Infrastructure
- Real Assets: Real Estate
- Venture Capital
- Professional Support and Business Services
- Real Estate
- Technology, Media and Telecommunications
- alt
- alt/alt-competition-regulation-and-trade
- alt/alt-corporate
- alt/alt-dispute-resolution
- alt/alt-employment-pensions-and-incentives
- alt/alt-finance-real-estate-and-projects
- Business and Human Rights
- Capital Markets
- Debt Capital Markets
- Equity Capital Markets
- High Yield
- US Securities
- Climate Change
- Competition, Regulation and Trade
- Antitrust
- Competition Litigation
- EU Regulation
- Economic Regulation
- Foreign Direct Investment
- International Trade and WTO
- Merger Control
- State Aid and Subsidy Control
- Corporate
- Corporate Governance
- Corporate Crime and Investigations
- Anti-bribery and Corruption
- Anti-money laundering
- Fraud and White Collar Crime
- Investigations
- Sanctions
- Crisis Prevention and Management
- Defamation and Reputation
- Defamation
- Health, Safety and Environmental Crisis Management
- Human Rights
- Cyber Risk Advisory
- Data Protection and Privacy
- Digital Legal Delivery
- Dispute Resolution
- Africa dispute resolution
- Civil Fraud
- Class Actions
- Commercial Litigation
- Construction and Infrastructure Disputes
- Directors' Liability
- Financial Services Disputes
- Insurance Disputes
- International Arbitration
- Commercial Arbitration
- Global Advocacy
- Investment Arbitration and Treaty Protection
- Public International Law
- Product liability
- Professional Negligence
- Public law and regulatory
- TMT Disputes
- Tax Investigations and Disputes
- Trusts and private client disputes
- ESG, Sustainability and Responsible Business
- Emerging Technology
- Artificial Intelligence
- Blockchain and Digital Assets
- Metaverse and Spatial
- Employment, Pensions and Incentives
- Employment
- Employment Litigation
- Industrial Relations
- Pensions and Pensions Litigation
- Remuneration and Incentives
- Superannuation
- Workplace Health and Safety
- Workplace and employment law training
- Environment, Planning and Communities
- Finance
- Acquisition and Leveraged Finance
- Asset Finance
- Corporate Debt Finance and Treasury
- Derivatives and structured products
- Energy, Natural Resources and Infrastructure Finance
- Project Finance
- Real Estate Finance
- Securitisation and Structured Finance
- Sustainable and Green Finance
- Financial Services Regulatory
- Compliance Advisory
- Enforcement and Investigations
- Governance and Risk Management
- Market Conduct
- Regulatory Change
- Transactions Regulatory Support
- IBOR Transition
- IBOR Transition: Implementation
- IBOR Transition: Regulatory/litigation risk
- IBOR Transition: Transactional
- IBOR transition: Bonds
- IBOR transition: Derivatives
- IBOR transition: Loans
- Impact Investment
- Impact Investors and Intermediaries
- Social Entrepreneurs
- Intellectual Property
- Copyright, Designs and Confidential Information
- Patents
- Standards, SEPs and FRAND disputes
- Trade Marks
- Legal Operations
- Legal Automation And Technology
- Legal Process Design
- Legal Project Management
- Litigation Funding And Insurance
- Pricing And Analytics
- Mergers and Acquisitions
- Joint Ventures and Investments
- Public mergers and acquisitions
- Native Title and Indigenous Heritage
- Partnerships and LLPs
- Private Wealth and Charities
- Projects
- Public Procurement
- Real Estate
- Construction and Engineering
- Corporate Real Estate
- Major Leasing
- Property Taxes
- Real Estate Acquisitions and Disposals
- Real Estate Development
- Real Estate Disputes
- Real Estate Funds
- Restructuring, Turnaround and Insolvency
- Distressed Investing
- Loan Portfolio Transactions
- Special Situation Financing
- Tax
- Technology, Media and Entertainment, and Telecommunications
- Digital Business
- Media and Entertainment
- Outsourcing
- Technology Transactions
- Telecommunications
Total 3 Results for:
Showing 3 out of 3 results
27 November 2020
Herbert Smith Freehills advises on Gland Pharma’s US$872 million India IPO / 史密夫斐尔律师事务所为Gland Pharma 8.72亿美元印度IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised the book running lead managers on the global offering and listing of Gland Pharma Limited on …
27 May 2020
Calls for increased domestic pharmaceutical production not warranted, say Herbert Smith Freehills experts
Increased commentary about Australia’s perceived vulnerability to pharmaceutical shortages have led to recent calls for an overhaul of the country’s …
17 July 2019
HERBERT SMITH FREEHILLS ADVISES STRIDES ON DISPOSAL OF AUSTRALIAN PHARMACEUTICAL BUSINESS
International law firm Herbert Smith Freehills has advised Strides Pharma Science Limited, an Indian listed pharmaceuticals company, on the AU$394 …
Showing 3 out of 3 results
Searchlight AI
Our new tracking tool keeps you current with developments in artificial intelligence in all major markets